Order Article Reprints

Qiu L, Medeiros LJ, Tang G, Khanlari M, Li S, Konoplev S, Wang SA, Yin CC, Khoury JD, Wang W, et al. The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis. Cancers. 2021; 13(24):6316. https://doi.org/10.3390/cancers13246316

Qiu, Lianqun, L. Jeffrey Medeiros, Guilin Tang, Mahsa Khanlari, Shaoying Li, Sergej Konoplev, Sa A. Wang, C. Cameron Yin, Joseph D. Khoury, Wei Wang, and et al. 2021. "The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis" Cancers 13, no. 24: 6316. https://doi.org/10.3390/cancers13246316

Qiu, L., Medeiros, L. J., Tang, G., Khanlari, M., Li, S., Konoplev, S., Wang, S. A., Yin, C. C., Khoury, J. D., Wang, W., Miranda, R. N., Iyer, S., You, M. J., & Xu, J. (2021). The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis. Cancers, 13(24), 6316. https://doi.org/10.3390/cancers13246316